Elevated intracellular calcium levels drive massive, unchecked ROS production that overwhelms the damaged clearance enzymes
Disclosure: this article is not intended to replace medical advice given to you by your physician
95% CI, -1.7 to -0.5 per 1000 person-years
Recent FDA approvals have expanded the indication for semaglutide to include the reduction of major adverse cardiovascular events (MACE), such as heart attack, stroke, and cardiovascular death, in adults with established cardiovascular disease and obesity
Because digoxin toxicity can present as nausea and vomiting, symptoms that overlap with GLP-1 RA side effects, maintain a low threshold for checking levels in any patient reporting new or worsening GI symptoms after a GLP-1 RA dose increase
PlexusDx sources all medications from licensed 503A compounding pharmacies, which maintain identical pharmaceutical standards as FDA-approved manufacturers